Bortezomib generic versus original
Recruiting
- Conditions
- Multiple myeloma requiring treatment patients who were treated with bortezomib based regimen.multiple myeloma, bortezomib, generic bortezomib, original bortezomib
- Registration Number
- TCTR20210927006
- Lead Sponsor
- /A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1)Patients diagnosed as multiple myeloma according to International Myeloma Working Group 2014 criteria
2)Performance status Estern Cooperative Oncology Group (ECOG) <3
3)Patients were treated with bortezomib-base regimen in the induction phase
Exclusion Criteria
Lack of information
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method progression free survival rate 2 years Progression or death
- Secondary Outcome Measures
Name Time Method Overall response rate after induction 4 cycles Rate of response